Form 4: Director David P. King Receives Privia Health Equity Grant
Statement of Changes in Beneficial Ownership
Privia Health Group, Inc. director David P. King was granted 8,463 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.
Summary
- Director David P. King acquired 8,463 restricted stock units (RSUs) on May 20, 2026.
- The grant was issued under the Privia Health Group, Inc. 2021 Omnibus Incentive Plan.
- Following this transaction, the reporting person's total beneficial ownership of common stock increased to 50,775 shares.
- The RSUs are scheduled to vest on the earlier of the day before the 2027 annual meeting or the first anniversary of the grant date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine regulatory filing regarding director compensation with no impact on company operations or financial health.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standard incentive structure utilized to retain board leadership.
Negatives
- None identified; this is a routine compensatory equity grant.
Risks
- None identified; this is a standard regulatory disclosure of director compensation.
Future Outlook
The RSUs are expected to vest in approximately one year, contingent upon the director's continued service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are a standard corporate governance practice in the healthcare services sector to ensure long-term alignment with shareholder value.
Comparison to Industry Standards
- The grant size and vesting schedule are consistent with typical director compensation packages for mid-cap healthcare companies.
- The use of an Omnibus Incentive Plan is standard practice for publicly traded firms.
Stakeholder Impact
- Minimal impact on shareholders as this is a standard compensatory grant.
Next Steps
- Vesting of the 8,463 RSUs on or before the 2027 annual meeting of stockholders.
Key Dates
| Date | Description |
|---|---|
| 05/20/2026 | Date of the RSU grant transaction. |
| 05/22/2026 | Date the Form 4 was filed with the SEC. |
Keywords
Privia Health, PRVA, Form 4, Insider Trading, Equity Compensation, Director Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.